Dong Huang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dong Huang has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Yan-Qing Liu
Department of Painology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3 shared publications - Zhixiang Cheng
Department of Painology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China
3 shared publications - Ke Ma
Department of Pain Medicine, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publications - Lin Wang
Department of Painology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China
2 shared publications - Tang-Hua Liu
Pain Research Institute, Zhongguancun Zhongmei Precision Medical Technology Research Institute, Beijing, China
2 shared publications - Xian-Guo Liu
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China
2 shared publications
Latest Publications
- Open Access
- 16 July 2026
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 2 (3) , 122-142
A Chinese Clinical Guideline for the Diagnosis and Treatment of Chronic Secondary Headache and Orofacial Pain
Secondary headaches and orofacial pains, caused by underlying diseases or dysfunctions, are more prevalent than primary headaches and orofacial pains. To date, no clinical guidelines have been established for the diagnosis and treatment of the 11 categories of chronic secondary headaches and orofacial pains on the “International Classification of Diseases, 11th Revision (ICD-11)”. To improve the recognition and management of these painful diseases and to standardize diagnostic and therapeutic practices among clinicians in China, the Expert Panel for the Development of Chinese Clinical Guidelines for Chronic Secondary Headache and Orofacial Pain (hereinafter referred to as Expert Panel) compiled the present guideline. This guideline focuses on 8 common chronic secondary headache and orofacial pain disorders that are frequently underdiagnosed or misdiagnosed, but have well-defined diagnostic and therapeutic protocols within the painology department currently. These disorders include: cervicogenic headache, trigeminal neuralgia, glossopharyngeal neuralgia, sphenopalatine neuralgia, temporomandibular joint disorders, head and facial herpes zoster-related neuralgia, post-stroke persistent headache, and cancer-related head and facial pain. The Expert Panel systematically retrieved and evaluated the available evidence on the definition, epidemiology, pathogenesis clinical manifestations, diagnostic criteria, differential diagnosis, treatment, and recent advances for each of the 8 disorders. The guideline provides recommendations for both pharmacological therapy and minimally invasive treatments based on the evidence, to serve as a practical reference for painologists, neurologists, general practitioners, and other healthcare professionals involved in the management of these chronic secondary headache and orofacial pain.
- 16 July 2026
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 2 (3) , 122-142
Open AccessA Chinese Clinical Guideline for the Diagnosis and Treatment of Chronic Secondary Headache and Orofacial Pain
Secondary headaches and orofacial pains, caused by underlying diseases or dysfunctions, are more prevalent than primary headaches and orofacial pains. To date, no clinical guidelines have been established for the diagnosis and treatment of the 11 categories of chronic secondary headaches and orofacial pains on the “International Classification of Diseases, 11th Revision (ICD-11)”. To improve the recognition and management of these painful diseases and to standardize diagnostic and therapeutic practices among clinicians in China, the Expert Panel for the Development of Chinese Clinical Guidelines for Chronic Secondary Headache and Orofacial Pain (hereinafter referred to as Expert Panel) compiled the present guideline. This guideline focuses on 8 common chronic secondary headache and orofacial pain disorders that are frequently underdiagnosed or misdiagnosed, but have well-defined diagnostic and therapeutic protocols within the painology department currently. These disorders include: cervicogenic headache, trigeminal neuralgia, glossopharyngeal neuralgia, sphenopalatine neuralgia, temporomandibular joint disorders, head and facial herpes zoster-related neuralgia, post-stroke persistent headache, and cancer-related head and facial pain. The Expert Panel systematically retrieved and evaluated the available evidence on the definition, epidemiology, pathogenesis clinical manifestations, diagnostic criteria, differential diagnosis, treatment, and recent advances for each of the 8 disorders. The guideline provides recommendations for both pharmacological therapy and minimally invasive treatments based on the evidence, to serve as a practical reference for painologists, neurologists, general practitioners, and other healthcare professionals involved in the management of these chronic secondary headache and orofacial pain.
- Open Access
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 157-171
Chinese Expert Consensus on Percutaneous Balloon Compression for Trigeminal Neuralgia (2022)
Percutaneous balloon compression (PBC) is recognized as a simple, safe, and effective intervention for trigeminal neuralgia (TN) and has been widely adopted in clinical practice across China. However, variations in its application exist among different regions. To standardize procedural protocols and enhance clinical outcomes, a multidisciplinary panel of Chinese experts from pain medicine and neurosurgery collaboratively developed this clinical expert consensus. The consensus formulation involved a systematic literature review of major databases, including Wanfang and PubMed, among others, and focusing on high-quality evidence such as systematic reviews, meta-analyses, randomized controlled trials, expert consensus statements, and clinical guidelines. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework and structured consensus conference methods, the panel held iterative discussions and conducted voting sessions to finalize the recommendations. This document summarizes key aspects of PBC, including relevant anatomy, mechanisms of action, indications, contraindications, detailed operative techniques, and efficacy evaluation. It aims to serve as a practical reference for clinicians to standardize and optimize the use of PBC in the treatment of trigeminal neuralgia.
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 157-171
Open AccessChinese Expert Consensus on Percutaneous Balloon Compression for Trigeminal Neuralgia (2022)
Percutaneous balloon compression (PBC) is recognized as a simple, safe, and effective intervention for trigeminal neuralgia (TN) and has been widely adopted in clinical practice across China. However, variations in its application exist among different regions. To standardize procedural protocols and enhance clinical outcomes, a multidisciplinary panel of Chinese experts from pain medicine and neurosurgery collaboratively developed this clinical expert consensus. The consensus formulation involved a systematic literature review of major databases, including Wanfang and PubMed, among others, and focusing on high-quality evidence such as systematic reviews, meta-analyses, randomized controlled trials, expert consensus statements, and clinical guidelines. Using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework and structured consensus conference methods, the panel held iterative discussions and conducted voting sessions to finalize the recommendations. This document summarizes key aspects of PBC, including relevant anatomy, mechanisms of action, indications, contraindications, detailed operative techniques, and efficacy evaluation. It aims to serve as a practical reference for clinicians to standardize and optimize the use of PBC in the treatment of trigeminal neuralgia.
- Open Access
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 107-131
A Chinese Guideline for the Diagnosis and Treatment of Chronic LOW Back Pain (2024 Edition)
Background: Low back pain (LBP) is the leading cause of disability worldwide, severely impairing patients' quality of life, consuming substantial healthcare resources, and increasing medical costs while reducing productivity. Low back pain has become the leading cause of disability worldwide and a major global public health issue. Objective: To enhance the ability of diagnosis and treatment for LBP to meet the needs of clinical diagnosis and treatment. Main ideas: Based on high quality evidence based medical research on the diagnosis and treatment of LBP published domestically and internationally between January 2010 and December 2023, the expert group of the Pain Disease Diagnosis and Treatment Special Capacity Enhancement Project of the National Health Commission of China's Capacity Building and Continuing Education Centerhas formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of LBP. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common chronic specific low back pain (cSLBP) and chronic non-specific low back pain (cNSLBP). Conclusion: LBP is characterized by high prevalence, significant disability rates, and frequent recurrence, imposing substantial burdens on individuals, families, and society. For patients, improving understanding of cLBP, practicing effective self-management, and actively cooperating with treatment are crucial for disease prognosis. Healthcare providers must enhance patient education and clinical competencies while strictly adhering to diagnostic and therapeutic guidelines for comprehensive cLBP management. Policymakers and academic organizations should focus on developing evidence-based clinical guidelines, strengthening healthcare system oversight, and promoting widespread implementation of standardized cLBP care protocols.
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 107-131
Open AccessA Chinese Guideline for the Diagnosis and Treatment of Chronic LOW Back Pain (2024 Edition)
Background: Low back pain (LBP) is the leading cause of disability worldwide, severely impairing patients' quality of life, consuming substantial healthcare resources, and increasing medical costs while reducing productivity. Low back pain has become the leading cause of disability worldwide and a major global public health issue. Objective: To enhance the ability of diagnosis and treatment for LBP to meet the needs of clinical diagnosis and treatment. Main ideas: Based on high quality evidence based medical research on the diagnosis and treatment of LBP published domestically and internationally between January 2010 and December 2023, the expert group of the Pain Disease Diagnosis and Treatment Special Capacity Enhancement Project of the National Health Commission of China's Capacity Building and Continuing Education Centerhas formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of LBP. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common chronic specific low back pain (cSLBP) and chronic non-specific low back pain (cNSLBP). Conclusion: LBP is characterized by high prevalence, significant disability rates, and frequent recurrence, imposing substantial burdens on individuals, families, and society. For patients, improving understanding of cLBP, practicing effective self-management, and actively cooperating with treatment are crucial for disease prognosis. Healthcare providers must enhance patient education and clinical competencies while strictly adhering to diagnostic and therapeutic guidelines for comprehensive cLBP management. Policymakers and academic organizations should focus on developing evidence-based clinical guidelines, strengthening healthcare system oversight, and promoting widespread implementation of standardized cLBP care protocols.
- Open Access
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 56-86
A Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.
- 9 October 2025
- Published by Science Publishing Group in International Journal of Pain Research
- Vol. 1 (4) , 56-86
Open AccessA Chinese Guideline for the Diagnosis and Treatment of Neuropathic Pain
Background : Neuropathic pain refers to pain caused by injury or disease affecting the somatosensory nervous system, which is a common and frequently occurring disease in clinical practice, and seriously affects patients' quality of life. However, the treatment of neuropathic pain is a clinical challenge. Objective : To standardize neuropathic pain management, the Pain Medicine Branch of China Association of Health Care for the Elderly convened an expert panel to develop the guideline. Main ideas : Based on high quality evidence-based medical research on the diagnosis and treatment of neuropathic pain published domestically and internationally in the past 10 years, the expert group has formed recommendations for common treatment methods through rigorous argumentation and expert voting, to provide references for standardized diagnosis and treatment of neuropathic pain. This guideline adopts GRADE methodology to evaluate the level of evidence and strength of recommendation for the treatments of common peripheral neuropathic pain and central neuropathic pain. Chinese traditional medicine also plays an important role in the treatment of neuropathic pain, so this guide also provides Chinese traditional medicine drugs and treatment recommendations. Conclusion : The Chinese pain community has proposed the principle of "treatment forward, early intervention, prevention of sensitization, and prevention and treatment of chronic pain", which has played a positive role in improving the clinical diagnosis and treatment level of neuropathic pain.